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Summary 
Costimulation mediated by the CD28  receptor has been shown to play an important role in 
the development of a vigorous T cell immune response. Nevertheless, CD28-deficient mice can 
mount effective T cell-dependent immune responses. These data suggest that other costimulatory 
molecules may play a role in T  cell activation. In a search for other costimulatory receptors on 
T  ceils,  we have characterized a monoclonal antibody (mAb) that can costimulate T  cells in 
the absence of accessory cells. Similar to CD28 antibodies, this mAb, R2/60, was found to synergize 
with T  cell receptor engagement in inducing proliferation.  Independent ligation of CD3 and 
the ligand recognized by R2/60 results in T cell proliferation, suggesting that the two molecules 
do not have to colocalize to activate the R2/60 costimulatory pathway. R2/60 does not react 
with CD28,  and furthermore, R2/60  costimulates in a CD28-independent fashion since the 
mAb costimulates T cells from the CD28-deficient mice as well as wild-type mice. Expression 
doning of the R2/60 antigen identified the ligand as murine CD43. Together, these data demonstrate 
that CD43 can serve as a receptor on T cells that can provide CD28-independent costimulation. 
T 
he generation of a T  cell response has been shown to 
depend on two independent signals (1). The first signal 
for activation is mediated by the interaction of the antigen- 
specific TCR with processed peptides displayed by APCs. This 
specific signal must be accompanied by a second costimula- 
tory signal(s)  delivered by the APC to the T  cells through 
cell-cell interactions or cytokines. The lack of costimulation 
prevents proliferation through the inhibition of autocrine lym- 
phokine production. Moreover, in the absence of a second 
signal,  some T  cells are induced into a state of nonrespon- 
siveness often called "anergy" (2). 
The nature of the costimulatory signal has recently been 
the subject of a large number of studies (3).  CD28, which 
is expressed on a majority of T  cells,  is a receptor for the 
costimulatory molecules B7-1 and B7-2 (4). Binding of CD28, 
by either mAb or B7 family members, has been shown to 
costimulate antigen-specific T cell responses (5, 6), aUogeneic 
mixed lymphocyte reactions (7, 8), and direct TCR- CD3 
Anne I. Sperling  (Bluestone  Laboratory)  and  Jonathan  M. Green  (Thompson 
Laboratory) contributed  equally to this work and should be considered 
co-first authors. 
activation through antibody-mediated stimulation (9). In ad- 
dition, the blocking of CD28/1igand interactions substan- 
tially, but not completely, inhibits these immune responses (3). 
Recent studies, however, have shown that mice rendered 
CD28-deficient through mutations introduced by homolo- 
gous recombination technology (CD28-/-),  develop normal 
immune responses to viral infections in vivo, and reject al- 
logeneic skin grafts (reference 10 and Green, J.  M.,  C.  B. 
Thompson,  and J.  A.  Bluestone,  unpublished  data).  The 
T  cells from these mice can mount accessory cell-dependent 
responses to alloantigens, lectins, and anti-CD3 antibodies, 
although the response is decreased compared to normal con- 
trol animals (10, 11). These data suggest that other cell sur- 
face molecules may provide costimulatory activity. 
In this report, we have identified an additional costimula- 
tory molecule on murine T cells distinct from CD28. This 
molecule is bound by a rat IgM mAb, R2/60, that was pro- 
duced after immunization with murine intestinal epithelial 
lymphocytes (12). We find that the R2/60 mAb, in the ab- 
sence of any other costimulatory interactions, can synergize 
with TCR engagement and induce T cell proliferation. In- 
dependent ligation of CD3  and the ligand recognized by 
R2/60,  also leads  to T  cell proliferation,  suggesting that 
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quire colocalization with the TCR-CD3 complex. The mAb 
also  costimulates  T  cells  from  CD28 -/-  mice  as  well  as 
wild-type T  cells,  thus  the R2/60-activated  costimulatory 
pathway is independent of CD28.  Using R2/60 to expres- 
sion clone the cDNA that produces the R2/60 antigen, we 
found that R2/60 was specific for murine CD43 (leukosialin, 
Ly-48). Thus, CD43 can provide CD28-independent costimu- 
lation  to T  cells. 
Materials  and Methods 
Mice.  C57BL/6 and BALB/c mice were purchased from the 
National Cancer Institute animal facility (Frederick, MD). CD28- 
deficient mice were previously described (10), and a colony of the 
CD28-deficient mice and wild-type (CD28 +/§  control mice were 
maintained in a specific pathogen-free animal facility at the Univer- 
sity of Chicago. 
Antibodies.  The procedure used to generate and isolate  mAb 
R2/60 has been previously reported (12). Control Rat IgM was 
purchased from Zymed Laboratories (South San Francisco,  CA). 
Hamster anti-routine CD28 (PV-1; reference 4) was a kind gift 
from Dr. Carl June (Naval Medical Research Institute, Bethesda, 
MD).  All other flow cytometry reagents were purchased from 
PharMingen (San Diego, CA). Culture supernatant or ascites of 
anti-CD3 (145-2Cll; reference 13), anti-heat-stable antigen (J11D; 
reference 14), anti-I-A b (25-9-3; reference 15), anti-I-A  d (MKD6; 
reference 16), and anti-Fc receptor (2.4G2; reference 17) were pre- 
pared in the laboratory, purified as required, and the cell lines are 
available from American Type Culture Collection (Rockville, MD). 
Alkaline phosphatase-conjugated goat anti-rat Ig (Jackson Labora- 
tories, Inc., West Grove, PA) was used to develop the Western blot 
stained with R2/60. Anti-CD43 ($7, rat IgG2a) was generously 
provided by J. Frelinger (Cancer Center, Immunology Division, 
University of Rochester, NY). Fab' fragments of the $7 antibody 
were made by standard methods and purity was confirmed by SDS- 
PAGE (data not shown). 
Flow Cytometry.  Two-color staining with directly conjugated 
FITC or biotinylated antibodies was done in the presence of anti- 
FcR (2.4G2) culture supernatant for 30 min. After washing, bio- 
tin reagents were developed with phycoerythrin-conjugated strep- 
tavidin (Southern Biotechnology Associates,  Birmingham, AL). 
Dead cells were excluded from the analysis by DNA staining with 
propidium iodide,  and  the cells were analyzed on a  FACScan  | 
(Becton Dickinson & Co.,  Mountain View,  CA). 
T Cell Purification and Proliferation Assays.  Lymph node T cells 
were purified as previously described (18). Briefly, total lymph node 
cells were passed through a nylon wool column, and nonadherent 
cells were collected. T cells were further purified by complement- 
mediated cytotoxic treatment with a mixture of anti-Ia (25-9-3 for 
I-A  b,  and  MKD6  for I-A  a)  and anti-heat-stable antigen  (J11D) 
antibodies.  Dead cells were removed by centrifugation through 
Ficoll-Hypaque. T cell purity was analyzed by flow cytometry and 
Con A stimulation. Purified T cells were consistently >97% CD3 
positive.  In experiments where the Con A response of the puri- 
fied T  cells was tested, the response of the purified T  cells was 
<2% of the response seen when irradiated Ia § APC were added 
(data  not  shown).  For mixed lymphocyte cultures,  total lymph 
node cells (4  x  l0 s) or purified T cells (2  x  10  s) from wild-type 
or CD28 -/-  mice were isolated  and cocultured with  105 irradi- 
ated BALB/c splenocytes. 
In some experiments, antibodies were diluted in PBS and im- 
mobilized to individual wells of 96-well flat bottom microtiter plates 
in a final volume of 200 pl. The plates were incubated at 37~ 
overnight. Before use, the plates were washed twice with unsup- 
plemented DMEM media (Gibco Laboratories, Grand Island, NY), 
and blocked for 15 min with DMEM media supplemented with 
10% heat-inactivated FCS, 100 U/ml penicillin,  100/~g/ml strep- 
tomycin, 0.29 mM t-glutamine, nonessential amino acids, 10 mM 
Hepes, and 5  x  10 -5 M  3-mercaptoethanol. 
Polystyrene beads (7  x  107) from Polysciences, Inc. (Warring- 
ton, PA) were independently coated with either 145-2Cll, R2/60, 
or control rat IgM by incubating 100/~g of purified mAb in 1 ml 
ofS00 mM sodium carbonate buffer at pH 8.5. After an overnight 
incubation at room temperature, the beads were washed four times 
to remove unbound antibody and were then used in experiments 
as noted. 
Purified T cells were cultured at 2  x  105 cells per well. Except 
when noted, experiments were pulsed with 1/zCi [3H]thymidine 
at 48 h after initiation of the culture, and harvested 16 h later. Plates 
were harvested on a 96-well harvester (Filtermate 196; Packard In- 
strument Co., Meriden, CT), and counts were read on a microplate 
scintillation counter (Topcount; Packard Instrument Co.). All data 
points were performed in triplicate,  and data were presented as 
mean  _+  SD. 
146stern Analysis.  Cells were washed twice in PBS and then lysed 
at a final concentration of 10  s cells per ml in 0.5%  NP-40 lysis 
buffer  (50  mM  Tris,  150  mM  NaC1,  5  mM  EDTA,  1  mM 
Na3VO4, 10/zg/ml leupeptin, 10/~g/ml aprotinin, 25/~M p-nitro- 
phenyl/r  10 mM NaF, and 10 mM iodoaceta- 
mide). 50 #1 of each lysate was separated on a 10% discontinuous 
Laemmli SDS-PAGE gel. The protein was transferred to nitrocellu- 
lose by electrotransfer apparatus.  Nonspecific binding was blocked 
by preincubating the blot overnight in PBS containing 5% dry 
milk. After washing,  the blot was incubated with 10% R2/60 cul- 
ture supernatant in TBST (10 mM "Iris, 150 mM NaC1, and 0.05% 
Tween 20) for 2 h, washed extensively, and developed with alkaline 
phsophatase-conjugated goat anti-rat IgG (jackson Laboratories). 
Nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl-l-phosphate 
substrates  were added. 
Expression Cloning.  The R2/60 antigen was cloned using the 
method of Seed and Aruffo (19). Briefly,.a cDNA library in the 
eukaryotic expression pCDNA1  (Invitrogen,  San  Diego,  CA), 
generously provided by Dr. L. Matis (Alexion Pharmaceuticals, New 
Haven, CT), was constructed from LPS-activated murine spleno- 
cytes and transiently transfected into COS-7 cells by DEAE-dextran. 
Cells expressing the R2/60 antigen were enriched by panning over 
R2/60 antibody-coated plates.  The episomal DNA was rescued 
by the method of Hirt (20) and subsequent rounds of transfection 
and panning were performed. After three rounds, individual clones 
were retransfected into COS-7 cells and screened by FACS  |  (Becton 
Dickinson & Co) analysis for R2/60 surface staining. Positive clones 
were isolated and sequence analysis was performed by the dideoxy 
method. 
Results 
The R2/60  mAb Provides Costimulation in the Absence of 
Accessory Cells.  In our search for novel costimulatory receptors 
on T  cells,  different mAbs were examined for their ability 
to augment  T  cell proliferation in the absence of accessory 
cells. One rat IgM monoclonal antibody, R2/60,  activated 
purified T cells when coimmobilized with submitogenic doses 
of anti-CD3  (Fig.  1 A).  The R2/60  mAb  increased  the 
proliferative response at all doses of anti-CD3,  but did not 
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Figure 1.  The R2/60 mAb can costimulate  anti-CD3-mediated  T cell 
proliferation in the absence  of APC and independent  of CD28 stimula- 
tion. (.4) Anti-CD3 (145-2Cll) was coimmobilized  with the R2/60 anti- 
body at the indicated  concentrations.  Purified  T cells were plated at 2 x 
10  s calls per well, and pulsed  with [3H]thymidine  at 48 h after the initia- 
tion of the culture, and harvested 16-18 h later. The data presented  are 
representative  of more  than 15 independent  experiments.  (B) T cells  from 
CD28-defident  mice  were  cultured  as described  above. The data presented 
are representative of three independent experiments. --[3-, anti-CD3 
alone; --O-,  +  R2/60 (4/~g/ml); --A--, +  control IgM (4/xg/ml). 
induce proliferation in the absence of coimmobilized anti-CD3. 
Thus, R2/60 cross-linking, in the absence of APC, can pro- 
vide a "second signal" necessary to induce T  cell prolifera- 
tion in response to suboptimal anti-CD3  stimulation. 
The Antigen Recognized by R2/60 Is Not CD28.  To test 
the relationship of the R2/60 ligand to CD28, its expression 
was analyzed in both wild-type and CD28-deficient mice. 
In contrast to CD28, R2/60 was expressed on a wide variety 
of cells (data not shown). Furthermore, the mAb was equally 
reactive with cells isolated from CD28-deficient mice (Fig. 
2). Thus,  these data excluded CD28 as a candidate for the 
R2/60  antigen. 
R2/60-mediated Costimulation is CD28 Independent.  Al- 
though R2/60 does not react with CD28, many of the fea- 
tures of the K2/60-mediated costimulation were function- 
ally similar to CD28 costimulation.  Thus, it was possible 
that signaling through R2/60 ligation was linked to CD28 
ligation and signaling. To address this possibility, the ability 
of R2/60 to augment the proliferation of T cells from CD28- 
deficient mice was studied. Purified T  cells from wild-type 
and CD28-/-  mice were cultured with submitogenic doses 
of anti-CD3 alone or in the presence of coimmobilized R2/60 
mAb or control mAb (Fig. 1 B). At all concentrations tested, 
R2/60  cross-linking  enhanced  the  proliferation  of  the 
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CD28 -/-  T  cells equivalently to wild-type T  cells. Thus, 
R2/60-mediated costimulatory signals do not require CD28 
ligation or expression, and therefore can function indepen- 
dently of CD28. 
R2/60-mediated Costimulation Is Not Dependent on Colocali- 
zation with the TCR.  The increased proliferation that occurs 
with the coimmobilization of R2/60 and anti-CD3 may be 
caused by  an  independent costimulatory  signal  delivered 
through the molecule recognized by R2/60, or alternatively, 
it may be caused by an increased adhesive interaction between 
TCR and anti-CD3. To distinguish between these possibili- 
ties, the R2/60 molecule and CD3 were independently ligated 
on purified T calls using polystyrene beads coated separately 
with either R2/60 mAb or anti-CD3 (Pig. 3). The R2/60- 
coated beads augmented the T cell proliferative response in- 
duced by anti-CD3-coated beads, but had no effect alone. 
Thus, the proliferative response was the result of a separate 
costimulatory signal, and not the result of increased adhe- 
sion of the T  cells to the immobilized anti-CD3. 
The Antigen Recognized by the R2/60 mAb is the Murine 
Homologue of CD43.  To begin to identify the antigen rec- 
ognized by R2/60, both flow cytometry and Western anal- 
yses of whole-cell lysates from various cell types were studied. 
Flow cytometric analysis demonstrated that the molecule rec- 
ognized by R2/60 mAb is expressed on a large number of 
cell types including T cells, B cells, thymocytes, monocytes, 
and fibroblasts (Fig. 2 and data not shown). Further biochem- 
ical studies demonstrated that R2/60 reacts with a protein 
of 115 kD apparent reel mass (Fig.  4). A second protein of 
105 kD mol mass was detected by the R2/60 mAb, and was 
expressed at varying levels in different populations. The ap- 
parent molecular weight of these proteins does not change 
when analyzed under reducing conditions (data not shown), 
indicating that the surface antigen detected by R2/60 is a 
monomeric protein with few, if any, intramolecular disulfide 
bonds. 
To identify the surface receptor recognized by the R2/60 
mAb, we undertook an expression cloning approach. COS-7 
ceils were transfected with a cDNA library from LPS-stimu- 
lated splenocytes.  Calls  that contained a plasmid coding for 
a protein recognized by the R2/60 antibody were enriched 
by panning over plates coated with the antibody. The episomal 
DNA was rescued and amplified in bacteria and then retrans- 
fected into COS. After repeating this for three cycles, individual 
clones were isolated and screened for their ability to direct 
surface expression of the R2/60  antigen (Fig.  5 A). Two 
independent clones were isolated and further characterized. 
Sequence analysis revealed the clones to be identical to the 
published sequence for the murine homologue of CD43 (leu- 
kosialin, Ly-48;  reference 21). Retransfection of one of the 
clones into COS-7 ceils demonstrated that both R2/60 and 
a commercially available anti-CD43 antibody recognized the 
transfected cells (Fig. 5 B and reference 22). Thus, the iden- 
tity of the surface receptor recognized by the R2/60 mAb 
is murine CD43. 
Costimulation  Mediated through CIM3  Requires Cross- 
linking.  We next examined whether the augmented prolifer- 
ation observed by the addition of anti-CD43 antibody was LYMPH NODE 
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Figure  2.  The R2/60-specific 
molecule is expressed on lympho- 
cytes and thymocytes fi:om CD28- 
deficient mice. Lymph node cells 
and thymocytes were stained with 
FITC-coupled  R2/60  and  PE- 
conjugated  anti-CD28. 
dependent on cross-linking of CD43 on the cell surface. One 
approach is to use monovalent Fab' fragments of an anti-CD43 
antibody. Since R2/60 is an IgM, another anti-CD43 anti- 
body, $7,  which is a rat IgG2a, was used for these experi- 
ments. As seen in Fig. 6, the addition of $7 augmented the 
proliferative response of alloantigen-activated T  cells from 
wild-type and CD28-deficient mice. When Fab' fragments 
from the $7 antibody were included, the proliferative response 
25000. 
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Figure  3.  R2/60-mediated costimulation does not require colocaliza- 
tion with the T cell receptor.  Polystyrene beads were coated with either 
anti-CD3 (2Cll), R2/60, or control rat IgM. The anti-CD3-coated beads 
were added as indicated,  and the R2/60 and rat IgM-coated beads were 
added at 2.5  x  104 beads per well. Cultures were pulsed and harvested 
as in Fig.  1. The data presented  are representative  of three experiments. 
-C~,  anti-CD3 beads alone; --O--,  +  R2/60 beads; --A-,  +  control 
IgM beads. 
was not enhanced. This suggests that cross-linking of CD43 
may be important since the addition of secondary antibody 
directed against the Fab' fragments reconstituted the costimula- 
tory activity of the $7 antibody. 
Discussion 
The two-signal hypothesis for T  cell activation has sug- 
gested that, in addition to a specific antigenic signal, T cell 
proliferation requires costimulatory signals provided by the 
accessory ceU. Many studies have demonstrated that CD28 
on T cells is a costimulatory receptor for activation, although 
T  cells from CD28-deficient mice are still  able to produce 
immune responses to pathogens (10). In addition, CD28-de- 
ficient T  cells can be activated in vitro and in vivo,  albeit 
at a lower magnitude than normal T cells (10, 11). One poten- 
tial explanation for these results is the existence of other co- 
stimulatory receptors on T cells. In this study, we describe 
the cloning and characterization of an alternative costimula- 
tory receptor on T cells. We have shown that the antibody 
R2/60 is specific for murine CD43.  Ligation of CD43 on 
murine T cells with this mAb synergizes with submitogenic 
doses of anti-CD3 mAb to induce the proliferation ofT ceils 
in the absence of accessory ceUs or CD28 signaling. Similar 
to our studies in the mouse, several groups have found that 
CD43 ligation can enhance the proliferation of human T ceUs 
(23, 24). Thus, CD43 may regulate T cell activation through 
a costimulatory pathway that is independent of CD28. 
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Figure  4.  lmmunoblotting with the R.2/60  mAb reveals proteins  of 
105 kD and 115 kD apparent  molecular weight.  (/1) COS cells (Lanes 
I, 3, and 5) and total lymph node cells (lanes 2, 4, and 6) were blotted 
with R2/60 (lanes 5 and 6), control rat IgM, 7D4 (c~-Ib2R; lanes 3 and 
4) and alkaline phosphatase-conjugated  goat anti-rat Ig (all lanes). (B) 
Total cell lysates of (lane I) COS cells, (lane 2) CHO cells transfected with 
mufine B7-1, (lane 3) CHO cells transfected with murine CD28, (lane 
4) blank,  (lane 5) total lymph node cells, (lane 6) T-depleted splenocytes, 
(lane 7) cell from lane 6 after LPS activation, (lane 8) purified lymph node 
T  cells, (lane 9) B-depleted splenocytes, and  (lane I0) cells from lane 9 
after Con A stimulation  were blotted with R2/60 followed by alkaline 
phosphatase-conjugated  goat anti-rat Ig. 
CD43 is a large mucin-like protein containing one N-linked 
carbohydrate and 70-90  O-linked oligosaccharides, and its 
apparent molecular weight varies between populations be- 
cause of differential glycosylation. The apparent molecular 
weights characterized in Fig. 3 are similar to those previously 
reported for CD43  (25).  Thus, these data suggest that the 
R2/60 antibody reacts with at least two alternatively glycosy- 
lated forms of CD43. 
The nature of the mechanism by which CD43 increases 
T cell proliferation is unknown. There are at least two pos- 
sible hypotheses that can be envisioned. First,  R2/60  may 
mimic a classical  signaling mechanism by which CD43  is 
ligated normally through interactions with ligand(s) leading 
to  a signal transduced through its cytoplasmic tail,  which 
results in the production of autocrine lymphokines. A role 
for signal transduction is supported by the need for cross- 
linking to  observe an augmented proliferative response.  It 
is important to note that the protein sequence of the intra- 
cellular region of murine CD43 gene is highly homologous 
with rat CD43 (90%) and human CD43 (72%) (21). This 
strong evolutionary  conservation suggest important functional 
activity for this region. In addition, several groups have shown 
that CD43 in T lymphocytes (26) and monocytes (27) is con- 
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Figure  5.  The R2/60 mAb identifies the murine homologue of CD43. 
COS-7 ceils transiently transfected with the phsmid DNA isolated through 
expression cloning were stained with (.'1) R2/60 or (B) anti-CD43 ($7; 
PharMingen). 
stitutively phosphorylated and hyperphosphorylated after ac- 
tivation. While the cytoplasmic CD43 sequence has no cata- 
lytic regions itself, these data suggest that it may associate 
with other protein kinases or signal transduction molecules. 
Other groups have shown a possible association of CD43 sig- 
naling with protein kinase C, but the nature of the associa- 
tion is not yet clear (28).  If CD43  functions by initiating 
a signal transduction cascade, it will be important to identify 
its ligand. This ligand(s) may be expressed on "professional 
APC" such as dendritic cells, macrophages, or activated B 
cells. Or alternatively, the ligand(s) may be expressed on cell 
types involved in cell homing or localized T  cell activation 
as in the germinal centers. Finally, it is possible that the ligand 
exists on the T cells, similar to what has been postulated for 
CD45 (29).  Previously, it has been found that intraceUular 
adhesion molecule 1 can bind CD43 and therefore, may be 
a potential ligand (30).  Further studies are necessary to de- 
termine the role ofintracellular adhesion molecule I or other 
potential ligands in the regulation ofT cell responses by CD43. 
A  second, nonclassical, mechanism may be proposed for 
CD43 function based on its biochemical features. Since CD43 
is a highly glycusylated, negatively charged molecule that is 
expressed at high levels on many lymphocytes, it is possible 
that cell-cell contact is impeded by its expression. This repul- 
sion may provide a physical restraint on the ability of APC 
to interact with T cells and to provide appropriate activation A  CD28 +/+ 
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Figure  6.  Anti-CD43 antibodies require cross-linking to augment the 
proliferative response of alloantigen-activated T cells. Lymph node cells 
from (.4) CD28 +/+ or (B) CD28 -/- mice were isolated and stimulated 
with irradiated allogeneic splenocytes in the presence of medium alone, 
control Ig (4/~g/ml), R2/60 (4 #g/m1), $7 (4/~g/ml), or Fab' fragments 
of $7 (50/zg/ml), and proliferation determined by tritiated thymidine in- 
corporation for the final 16 h of a 64-h culture. (C) Purified T calls from 
C57BL/6 mice were cultured as above in the presence of medium alone, 
$7 (0.5/~g/ml), $7 Fab' (50/~g/ml) alone, or with the inclusion of a goat 
anti-rat Ig (20/~g/ml) to cross-link the bound Fab' fragments. 
signals. CD43 has been found to be proteolytically cleaved 
from the surface of activated lymphocytes and granulocytes 
(31), especially when CD43 was directly cross-linked. In ad- 
dition, a soluble galactoglycoprotein (Galgp), found in high 
concentrations in human serum, has been found to have exact 
sequence identity with the extracellular region of CD43 (32). 
Thus,  a  second  possible  mechanism  for  CD43-mediated 
costimulation of T cells may be that shedding of the extracel- 
lular domain may enhance intercellular interactions, and there- 
fore, critical receptor/ligand interactions. This mechanism does 
not exclude the need for an intracellular signal to be gener- 
ated by CD43. This hypothesis is supported by recent reports 
demonstrating that transfection  of HeLa cells with CD43 
actually reduces the ability of these cells to bind to T cells 
(33), and that targeted disruption of the CD43 gene in the 
CEM T cell line increases cellular adhesion (34). However, 
we and others have found an increased level of expression of 
CD43 when T cells are activated with Con A or CD3 (refer- 
ence 35  and data  not shown). Therefore,  the proteolytic 
cleavage of CD43 from the surface of lymphocytes may not 
be a necessary consequence of lymphocyte activation.  Fur- 
ther studies will be necessary to distinguish the two poten- 
tial mechanisms of CD43-mediated costimulation. 
The exact role of CD43 in the T cell immune response 
remains to be determined. While we have found that anti- 
CD43 can costimulate T cell responses, it is not known under 
what circumstances CD43 ligation is necessary for T cell ac- 
tivation.  Fab' fragments of an anti-CD43 antibody failed to 
inhibit alloantigen activation of lymph node cells; however, 
there are multiple possible explanations for this result. It is 
possible that the antibody recognizes an epitope on CD43 
different from the natural ligand, and therefore may not be 
able to sterically hinder receptor-ligand interactions.  This 
would be especially likely if the ligand for CD43 is a c-type 
lectin that interacts with the extensive terminal carbohydrate 
modifications of CD43. In addition, the difference in affinity 
of the natural ligand as compared to the Fab' fragments for 
CD43 may be too great to allow for effective competition. 
Although flow cytometry staining with $7 was blocked by 
Fab' fragments, the Fab' bound with significantly  lower affinity 
than whole antibody (data not shown). Future studies using 
a variety of genetic and molecular approaches will provide 
important insights  into both the functional role of CD43 
in T cell costimulation and the mechanism by which CD43 
mediates its  function. 
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